A familial case of DICER1 syndrome in a patient with pleuropulmonary blastoma
- Authors: Teleshova M.V.1, Yasko L.A.1, Maslenkova E.V.2, Merkulov N.N.1, Konovalov D.M.1, Kurnikova M.A.1, Doronina I.V.3, Shamanskaya T.V.1, Kachanov D.Y.1
-
Affiliations:
- Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation
- N.I. Pirogov Russian National Research Medical University of Ministry of Healthcare of the Russian Federation
- Murmansk Regional Children's Clinical Hospital
- Issue: Vol 21, No 4 (2022)
- Pages: 134-141
- Section: CLINICAL OBSERVATIONS
- Submitted: 27.07.2022
- Accepted: 07.09.2022
- Published: 26.12.2022
- URL: https://hemoncim.com/jour/article/view/639
- DOI: https://doi.org/10.24287/1726-1708-2022-21-4-134-141
- ID: 639
Cite item
Full Text
Abstract
Pleuropulmonary blastoma (PPB) is a very rare tumor of childhood that arises from the mesenchyme of the lung and is associated with mutations in the DICER1 gene. The present article describes a familial case of DICER1 syndrome in a patient aged 3 years and 11 months who underwent investigations and treatment for type II/III PPB of the lower lobe of the left lung at the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation. The patient's parents gave their consent to the use of their child's data, including photographs, for research purposes and in publications. The diagnosis was made based on the results of the pathology investigation of the tissue obtained by open biopsy. Furthermore, the diagnosis was confirmed by the review of histological specimens in the International PPB Registry (Minneapolis, USA). According to the data from the chest CT with intravenous contrast enhancement, the tumor was described as a mass consisting of cystic cavities of various calibers accumulating a contrast agent along the periphery, and a solid component. Specific combination treatment was based on the recommendations of the International PPB Registry and included chemotherapy according to the IVADo/IVA regimen and surgical treatment as a local control. Currently, specific treatment has been completed, the patient is alive with no signs of the disease, the follow-up period was 20 months. As regards the patient's family history, he has a sibling (older brother) who was diagnosed with a cystic nephroma at the age of 1 year and 4 months. Molecular genetic testing of the tumor tissues obtained from the patient (PPB) and his sibling (cystic nephroma) revealed pathogenic somatic variants in the DICER1 gene. Along with the somatic genetic variants, another pathogenic variant was found in both children, the germline status of which was confirmed. The germline variant in the DICER1 gene was inherited from the mother. Thus, the investigations confirmed a familial case of DICER1 syndrome. The case described in this article indicates that families in which DICER1 syndrome was found require special management aimed at early detection of tumors and non-tumor conditions associated with this syndrome in the carriers of pathogenic alleles.
About the authors
M. V. Teleshova
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation
Author for correspondence.
Email: teleshova_m@mail.ru
ORCID iD: 0000-0003-4042-0125
a pediatric oncologist of the Department of Clinical Oncology
Russian Federation, 117997, Moscow, Samory Mashela St., 1L. A. Yasko
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation
Email: teleshova_m@mail.ru
ORCID iD: 0000-0003-3007-3772
Moscow
Russian FederationE. V. Maslenkova
N.I. Pirogov Russian National Research Medical University of Ministry of Healthcare of the Russian Federation
Email: teleshova_m@mail.ru
ORCID iD: 0000-0001-6818-4027
Moscow
Russian FederationN. N. Merkulov
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation
Email: teleshova_m@mail.ru
ORCID iD: 0000-0003-0404-6420
Moscow
Russian FederationD. M. Konovalov
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation
Email: teleshova_m@mail.ru
ORCID iD: 0000-0001-7732-8184
Moscow
Russian FederationM. A. Kurnikova
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation
Email: teleshova_m@mail.ru
ORCID iD: 0000-0003-0900-6874
Moscow
Russian FederationI. V. Doronina
Murmansk Regional Children's Clinical Hospital
Email: teleshova_m@mail.ru
Murmansk
Russian FederationT. V. Shamanskaya
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation
Email: teleshova_m@mail.ru
ORCID iD: 0000-0002-3767-4477
Moscow
Russian FederationD. Yu. Kachanov
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation
ORCID iD: 0000-0002-3704-8783
Moscow
Russian FederationReferences
- Manivel J.C., Priest J.R., Watterson J., Steiner M., Woods W.G., Wick M.R., et al. Pleuropulmonary blastoma. The so-called pulmonary blastoma of childhood. Cancer. 1988; 62 (8): 1516–26. doi: 10.1002/1097-0142(19881015)62:8<1516::aid-cncr2820620812>3.0.co;2-3
- Dishop M.K., Kuruvilla S. Primary and metastatic lung tumors in the pediatric population: a review and 25-year experience at a large children's hospital. Arch Pathol Lab Med 2008; 132 (7): 1079–103. doi: 10.5858/2008-132-1079-PAMLTI
- Schultz K.A.P., Williams G.M., Kamihara J., Stewart D.R., Harris A.K., Bauer A.J., et al. DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies. Clin Cancer Res 2018; 24 (10): 2251–61. doi: 10.1158/1078-0432.CCR-17-3089
- Schultz K.A.P., Stewart D.R., Kamihara J., Bauer A.J., Merideth M.A., Stratton P., et al. DICER1 Tumor Predisposition. 2014 Apr 24 [updated 2020 Apr 30]. In: Adam M.P., Mirzaa G.M., Pagon R.A., Wallace S.E., Bean L.J.H., Gripp K.W., Amemiya A. (eds.). GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2022.
- Messinger Y.H., Stewart D.R., Priest J.R., Williams G.M., Harris A.K., Schultz K.A.P., et al. Pleuropulmonary blastoma: a report on 350 central pathology-confirmed pleuropulmonary blastoma cases by the International Pleuropulmonary Blastoma Registry. Cancer 2015; 121 (2): 276–85. doi: 10.1002/cncr.29032
- Caroleo A.M., De Ioris M.A., Boccuto L., Alessi I., Del Baldo G., Cacchione A., et al. DICER1 Syndrome and Cancer Predisposition: From a Rare Pediatric Tumor to Lifetime Risk. Front Oncol 2021; 10: 614541. doi: 10.3389/fonc.2020.614541
- Hill D.A., Jarzembowski J.A., Priest J.R., Williams G.M., Schoettler P., Dehner L.P. Type I pleuropulmonary blastoma: pathology and biology study of 51 cases from the international pleuropulmonary blastoma registry. Am J Surg Pathol 2008; 32 (2): 282–95. doi: 10.1097/PAS.0b013e3181484165
- Bisogno G., Brennan B., Orbach D., Stachowicz-Stencel T., Cecchetto G., Indolfi P., et al. Treatment and prognostic factors in pleuropulmonary blastoma: an EXPeRT report. Eur J Cancer 2014; 50 (1): 178–84. doi: 10.1016/j.ejca.2013.08.015
- Priest J.R., Magnuson J., Williams G.M., Abromowitch M., Byrd R., Sprinz P., et al. Cerebral metastasis and other central nervous system complications of pleuropulmonary blastoma. Pediatr Blood Cancer 2007; 49 (3): 266–73. doi: 10.1002/pbc.20937
- Bisogno G., Sarnacki S., Stachowicz-Stencel T., Minard Colin V., Ferrari A., Godzinski J., et al. Pleuropulmonary blastoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations. Pediatr Blood Cancer 2021; 68 Suppl 4: e29045. doi: 10.1002/pbc.29045
- Sparber-Sauer M., Tagarelli A., Seitz G., Sorg B., Bien E., Bel-Ami T., et al. Children with progressive and relapsed pleuropulmonary blastoma: A European collaborative analysis. Pediatr Blood Cancer 2021; 68 (12): e29268. doi: 10.1002/pbc.29268
- Priest J.R., Watterson J., Strong L., Huff V., Woods W.G., Byrd R.L., et al. Pleuropulmonary blastoma: a marker for familial disease. J Pediatr 1996; 128 (2): 220–4. doi: 10.1016/s0022-3476(96)70393-1
- Hill D.A., Ivanovich J., Priest J.R., Gurnett C.A., Dehner L.P., Desruisseau D., et al. DICER1 mutations in familial pleuropulmonary blastoma. Science 2009; 325 (5943): 965. doi: 10.1126/science.1174334
- Robertson J.C., Jorcyk C.L., Oxford J.T. DICER1 Syndrome: DICER1 Mutations in Rare Cancers. Cancers (Basel) 2018; 10 (5): 143. doi: 10.3390/cancers10050143
- Brenneman M., Field A., Yang J., Williams G., Doros L., Rossi C., et al. Temporal order of RNase IIIb and loss-of-function mutations during development determines phenotype in DICER1 syndrome: a unique variant of the two-hit tumor suppression model. F1000Res 2015; 4: 214. doi: 10.12688/f1000research.6746.2
- Kim J., Amanda F., Schultz K.A.P., Hill D.A., Stewart D.R. The prevalence of DICER1 pathogenic variation in population databases. Int J Cancer 2017; 141 (10): 2030–6. doi: 10.1002/ijc.30907
- Шульц К.Э.П., Вилльямс Г.М., Качанов Д.Ю., Варфоломеева С.Р., Хилл Э.Д., Денер Л.П. и соавт. DICER1-синдром и плевропульмональная бластома: отчет Международного регистра плевропульмональной бластомы. Российский журнал детской гематологии и онкологии 2017; 4 (4): 9–19. doi: 10.17650/2311-1267-2017-4-4-13-19
- Doros L.A., Rossi C.T., Yang J., Field A., Williams G.M., Messinger Y., et al. DICER1 mutations in childhood cystic nephroma and its relationship to DICER1-renal sarcoma. Mod Pathol 2014; 27 (9): 1267–80. doi: 10.1038/modpathol.2013.242
- Stewart D.R., Best A.F., Williams G.M., Harney L.A., Carr A.G., Harris A.K., et al. Neoplasm Risk Among Individuals with a Pathogenic Germline Variant in DICER1. J Clin Oncol 2019; 37 (8): 668–76. doi: 10.1200/JCO.2018.78.4678
- Kantor N., Wayne C., Nasr A. Symptom development in originally asymptomatic CPAM diagnosed prenatally: a systematic review. Pediatr Surg Int 2018; 34 (6): 613–20. doi: 10.1007/s00383-018-4264-y
- Feinberg A., Hall N.J., Williams G.M., Schultz K.A.P., Miniati D., Hill D.A., et al. Can congenital pulmonary airway malformation be distinguished from Type I pleuropulmonary blastoma based on clinical and radiological features? J Pediatr Surg 2016; 51 (1): 33–7. doi: 10.1016/j.jpedsurg.2015.10.019
Supplementary files
